Alternative formulations of paclitaxel

Cancer Treatment Reviews

Volumn 23, Issue 2, 1997, Pages 87-95

  Meerum Terwogt, J M ^a,b   Nuijen, B ^b   Ten Bokkel Huinink, W W ^a   Beijnen, J H ^a,b,c  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CREMOPHOR; CYCLODEXTRIN; FCE 28161; LIPOSOME; PACLITAXEL; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CONTROLLED STUDY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SOLUBILITY; DRUG STRUCTURE; EMULSION; INTRAVENOUS DRUG ADMINISTRATION; MICROCAPSULE; MICROENCAPSULATION; MOUSE; NONHUMAN; OVARY CANCER; REVIEW;

EID: 0030852617     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90022-0     Document Type: Article

References (32)

1. Huizing, M. T., Sewberath Misser, V. H., Pieters, R. C, et al. (1995) Taxanes: a new class of antitumour agents. Cancer Invest. 13: 381-404.
2. Suffness, M. (ed.) (1996) Biopharmaceutics of Paclitaxel (Taxol): Formulation, Activity and Pharmacokinetics - Taxol®: Science and Applications. Straubinger, CRC Press, Boca Raton, pp. 237-258.
3. Adams, J. D., Flora, K. P., Goldspiel, B. R. et al. (1993) Taxol: a history of pharmaceutical development and current pharmaceutical concerns. J. Natl. Cancer Inst. 15: 141-147.
4. Lorenz, W., Reimann, H. J., Schmal, A. et al. (1977) Histamine release in dogs by Cremophor EL and its derivatives. Agents Actions 7: 63-67.
5. Sparreboom, A., van Tellingen, O., Nooijen, W. J. et al. (1996) Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. Cancer Res. 56: 2112-2115.
6. Sykes, E., Woodburn, K., Decker, D. et al. (1994) Effects of Cremophor EL on distribution of taxol to serum lipoproteins. Br. J. Cancer 70: 401-404.
7. Liebmann, J., Cook, J., Lipschultz, C. et al. (1994) The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumour cell lines. Cancer Chem. Pharm. 33: 331-339.
8. Jonkman-de Vries, J. D., Flora, K. P., Bult, A. et al. (1996) Pharmaceutical development of investigational anticancer agents for parenteral use - a review. Drug Dev. Ind. Pharm. 22: 475-494.
9. Davis, S. S., Washington, C., West, P. et al. (1987) Lipid emulsions as drug delivery systems. Ann. NY Acad. Sci. 709: 75-88.
10. Hansrani, P. K., Davis, S. S. & Groves, M. J. (1983) The preparation and properties of sterile intravenous emulsions. J. Parent. Sci. Technol. 4: 145-150.
11. Tarr, B. D., Sambadan, T. G. & Yalkowski, S. H. (1987) A new parenteral emulsion for the administration of Taxol. Pharm. Res. 4: 162-165.
12. Vyas, D. M. (1995) Paclitaxel (Taxol) formulation and prodrugs. In: Farina, V. ed., The Chemistry and Pharmacology of Taxol and its Derivatives. Amsterdam: Elsevier Science BV, pp. 103-130.
13. Mellado, W., Magri, N. F., Kingston, D. G. I. et al. (1984) Preparation and biological of Taxol acetates. Biochem. Biophys. Res. Com. 124: 329-336.
14. Mathew, A. E., Mejilano, M. R., Nath, J. P. et al. (1992) Synthesis and evaluation of some water soluble prodrugs and derivatives of Taxol with antitumour activity. J. Med. Chem. 35: 141-151.
15. Nicolao, K. C., Dai, W. M. & Guy, R. K. (1993) Design, synthesis and biological activity of protaxols. Nature 364: 464-466.
16. Greenwald, R. B., Pendri, A., Bolikal, D. et al. (1994) Highly water soluble taxol derivatives: 2′ polyethylene glycol esters as potential prodrugs. Bioorg. Med. Chem. Lett. 4: 2465-2470.
17. Greenwald, R. B., Gilbert, C. W., Pendri, A. et al. (1996) Drug delivery systems: water soluble taxol 2′ poly(ethylene glycol) ester prodrugs - design and in vivo effectiveness. J. Med. Chem. 39: 424-431.
18. Presenti, E., Franzetti, C., Biasoli, G. et al. (1995) Synthesis and biological activity of water soluble polymer-bound taxol derivatives. Proc. Am. Ass. Cancer Res. 36: 307.
19. Ueda, Y., Wong, H., Matiskella, J. D. et al. (1993) Synthesis and antitumour evaluation of 2′ oxycarbonylpaclitaxels (paclitaxel-2′-carbonates). Bioorg. Med. Chem. Lett. 4: 1861-1864.
20. Vyas, D. M., Ueda, Y, Wong, H. et al. (1995) Phosphate-activated prodrugs of paclitaxel. Am. Chem. Soc. Symposium Series 9: 124-137.
21. Ueda, Y., Mikkilineni, A. B., Knipe, J. O. et al. (1993) Novel water soluble phosphate prodrugs of Taxol possessing in vivo antitumour activity. Bioorg. Med. Chem. Lett. 3: 1761-1766.
22. Ostro, M. J. & Cullis, P. R. (1989) Use of liposomes as injectable-drug-delivery systems. Am. J. Hosp. Pharm. 46: 1576-1587.
23. Chen, T., Lausier, J. M., Rhodes, C. T. (1986) Possible strategies for the formulation of antineoplastic drugs. Drug Dev. Ind. Pharm. 12: 1041-1106.
24. Alkan-Onyuksel, H., Ramakrishnan, S., Chai, H. B. et al. (1994) A mixed micellar formulation suitable for thé parenteral administration of taxol. Pharm. Res. 11: 206-212.
25. Bartoli, M. H., Boitard, M., Fessi, H. et al. (1990) In vitro and in vivo antitumoural activity of free and encapsulated taxol. J. Microencapsulation 7: 191-197.
26. Sharma, A., Mayhew, E. & Straubinger, R. M. (1993) Antitumour effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res. 53: 5877-5881.
27. Sharma, A. & Straubinger, R. M. (1994) Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm. Res. 11: 889-896.
28. Straubinger, R. M., Sharma, A., Murray, M. et al. (1993) Novel taxol formulations: taxolcontaining liposomes. J. Nat. Cancer Inst. Mon. 15: 69-78.
29. Dordunoo, S. K., Jackson, J. K., Arsenault, L. A. et al. (1995) Taxol encapsulation in poly(∈-caprolactone) microspheres. Cancer Chem. Pharm. 36: 279-282.
30. Burt, H. M., Jackson, J. K., Bains, S. K. et al. (1995) Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly(d,l-lactic) acid. Cancer Lett. 88: 73-79.
31. Bekers, O., Uijtendaal, E. V., Beijnen, J. H. et al. (1991) Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm. 17: 1503-1549.
32. Sharma, U. S., Balasubramanian, S. V. & Straubinger, R. M. (1995) Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. Am. Chem. Soc. Am. Pharm. Ass. 84: 1223-1230.